Outcomes of splenectomy versus cladribine for hairy cell leukemia in resource limited settings

Leuk Lymphoma. 2014 Jun;55(6):1428-30. doi: 10.3109/10428194.2013.839786. Epub 2013 Nov 1.

Authors

Deepesh P Lad¹, Pankaj Malhotra, Alka Khadwal, Gaurav Prakash, Vikas Suri, Savita Kumari, Sanjay Jain, Reena Das, Neelam Varma, Subhash Varma

Affiliation

¹ Clinical Hematology, Department of Internal Medicine.

PMID: 24001131
DOI: 10.3109/10428194.2013.839786

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Agents / therapeutic use*
Cladribine / therapeutic use*
Cost-Benefit Analysis
Developing Countries
Humans
Leukemia, Hairy Cell / drug therapy*
Leukemia, Hairy Cell / surgery*
Retrospective Studies
Splenectomy*
Treatment Outcome

Substances

Antineoplastic Agents
Cladribine